# Fibrinolytic (clot-dissolving) drugs

Drug · id `cardio:fibrinolytic-clot-dissolving-drugs` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: Fibrinolytic agents; Thrombolytics; Thrombolytic drugs

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease; Stroke; Acute care and long-term living  

## In plain language

Fibrinolytic drugs, also called thrombolytics, are medicines that dissolve blood clots that have already formed. MedlinePlus says they may be given for large clots in the lung that cause severe symptoms or other serious complications, and that they can cause sudden bleeding, so they are used when the pulmonary embolism is serious and may be life-threatening. This is the class page: each medicine has its own page.

## Technical summary

Class page. MeSH heading D005343, Fibrinolytic Agents, is an exact match, with the scope note fibrinolysin or agents that convert plasminogen to fibrinolysin. The one product label read, for alteplase, says the medicine binds to fibrin in a thrombus and converts the entrapped plasminogen to plasmin, which starts local fibrinolysis. The label lists acute ischemic stroke, acute myocardial infarction and acute massive pulmonary embolism as uses. The MedlinePlus statement concerns pulmonary embolism only. No trial result and no dose is recorded here.

## Connected pages

- Files under this front: Medicines (`cardio:front-medicines`)
- Named beside anticoagulants among pulmonary embolism medicines by MedlinePlus: Anticoagulants (`cardio:anticoagulants`)
- A procedure that can deliver medicine through a catheter: Catheter-directed therapy for pulmonary embolism and DVT (`cardio:catheter-directed-therapy-for-pulmonary-embolism-and-dvt`)
- Related condition: Pulmonary embolism (`cardio:pulmonary-embolism`)
- Related condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Related condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Has subtype: Alteplase (Activase) (`cardio:alteplase`)
- Has subtype: Tenecteplase (`cardio:tenecteplase`)

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 32 registry trials

## Provenance

Content hash: 130ad03cec0f571148915156f114b4455b2026079cbca001c326969de2e8a672
Last substantive edit: 2026-11-09
Evidence last checked: 2026-11-09
